The Smartest Investors Club
  • Business
  • Politics
  • Investing
  • World
  • Business
  • Politics
  • Investing
  • World

The Smartest Investors Club

Investing

RAD receives IND approval from US FDA for Betabart (RV-01)

by July 28, 2025
July 28, 2025
RAD receives IND approval from US FDA for Betabart (RV-01)

Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01)

Download the PDF here.

This post appeared first on investingnews.com
0
FacebookTwitterGoogle +Pinterest
previous post
Maiden Drill Program Commences at Oasis Uranium Project
next post
Agreement to Develop New Expandable Graphite Facility

You may also like

Harvest Gold Announces Annual General Meeting Results

Almonty Shares Rise on Nasdaq Debut Amid US...

Widespread Natural Rutile Observed Throughout the Central Rutile...

Completion of Silver Acquisition & Appointment of New...

Pinnacle Engages ITG as Market Maker and Closes...

MAC: Canada Must Accelerate Investment to Unlock Mining...

Anteros Discovers High-Grade Copper-Gold-Silver in Untested Target Area...

From Proof of Work to Useful Work: Bitcoin’s...

Radisson Announces Positive Preliminary Economic Assessment for O’Brien...

Element79 Gold Corp to Present at the Metals...

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest

    • Homerun Resources Inc. Receives Joint Support Plan from BNDES and FINEP Indicating...

    • Galan Lithium Limited: Incentive Regime for HMW Project in Argentina

    • Anteros Metals Initiates Channel Sampling at Havens Steady Following Grant Confirmation and Exploration Permit Approval

    • Allied Critical Metals Launches Allied USA to Expand Tungsten Import and Distribution Operations, Lists on OTCQB, and Receives DTC Eligibility

    • Radiopharm Theranostics Receives IND approval from US FDA to Initiate Phase I Therapeutic Clinical Study to target B7H3 with Betabart

    Categories

    • Business (70)
    • Investing (523)
    • Politics (700)
    • World (262)
    • Terms & Conditions
    • Privacy Policy
    • About us

    Disclaimer: thesmartestinvestorsclub.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 thesmartestinvestorsclub.com | All Rights Reserved


    Back To Top